Iyengar Capital Partners focuses on investing in innovative medical device companies during the clinical development stage. Based in Texas, the firm targets ventures that demonstrate potential for success in a value-oriented healthcare system. Their investments typically fall within Series A and Series B rounds, with a particular emphasis on higher-risk, higher-return opportunities compared to private equity or growth equity investments.